Strategy to Commercialize Biosimilar in European Union.

      Аннотация: This book is written precisely to develop competencies, capabilities to sail through the stormy way of commercialization of bio-similar in the most competent and competitive European market. The book gives clear cut strategy of how to enter in the EU market with all pros and corns. It also gives hypothesis for the break even along with different marketing strategies to penetrate the market. The potential five counties are studies to make the effective executable business strategy.

Ключевые слова: COMPETENCY, Strategy to Commercialize Biosimilar in European Union, regulatory to break even pathways